share_log

Bioceres Crop Solutions Analyst Ratings

Benzinga ·  Aug 16, 2023 09:59
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/16/2023 174.09% Roth MKM → $31 Reiterates Buy → Buy
04/06/2023 32.63% Oppenheimer → $15 Initiates Coverage On → Outperform
09/30/2022 98.94% Canaccord Genuity → $22.5 Initiates Coverage On → Buy
10/08/2021 85.68% Roth Capital → $21 Initiates Coverage On → Buy
03/15/2021 32.63% Lake Street → $15 Initiates Coverage On → Buy

What is the target price for Bioceres Crop Solutions (BIOX)?

The latest price target for Bioceres Crop Solutions (NASDAQ: BIOX) was reported by Oppenheimer on April 6, 2023. The analyst firm set a price target for $15.00 expecting BIOX to rise to within 12 months (a possible 32.63% upside). 2 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Bioceres Crop Solutions (BIOX)?

The latest analyst rating for Bioceres Crop Solutions (NASDAQ: BIOX) was provided by Oppenheimer, and Bioceres Crop Solutions initiated their outperform rating.

When is the next analyst rating going to be posted or updated for Bioceres Crop Solutions (BIOX)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bioceres Crop Solutions, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bioceres Crop Solutions was filed on April 6, 2023 so you should expect the next rating to be made available sometime around April 6, 2024.

Is the Analyst Rating Bioceres Crop Solutions (BIOX) correct?

While ratings are subjective and will change, the latest Bioceres Crop Solutions (BIOX) rating was a initiated with a price target of $0.00 to $15.00. The current price Bioceres Crop Solutions (BIOX) is trading at is $11.31, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment